Researchers discovered that gain-of-function mutations in the PCSK9 gene cause hypercholesterolemia and that loss-of-function mutations in the PCSK9 gene resulted in the opposite (64–66). This evidence concerns the gene PCSK9 and familial hypercholesterolemia.